Credit Suisse’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.32M | Sell |
100,544
-10,289
| -9% | -$340K | ﹤0.01% | 1537 |
|
|
2023
Q4 | $3.02M | Sell |
110,833
-13,734
| -11% | -$374K | ﹤0.01% | 1636 |
|
|
2023
Q3 | $3M | Buy |
124,567
+28,522
| +30% | +$686K | ﹤0.01% | 1571 |
|
|
2023
Q2 | $3.07M | Buy |
96,045
+17,974
| +23% | +$574K | ﹤0.01% | 1643 |
|
|
2023
Q1 | $2.39M | Buy |
78,071
+3,805
| +5% | +$117K | ﹤0.01% | 1745 |
|
|
2022
Q4 | $2.9M | Buy |
74,266
+16,398
| +28% | +$641K | ﹤0.01% | 1646 |
|
|
2022
Q3 | $2.76M | Buy |
57,868
+3,725
| +7% | +$177K | ﹤0.01% | 1624 |
|
|
2022
Q2 | $2.1M | Buy |
54,143
+8,919
| +20% | +$345K | ﹤0.01% | 1864 |
|
|
2022
Q1 | $2.59M | Sell |
45,224
-9,149
| -17% | -$524K | ﹤0.01% | 1895 |
|
|
2021
Q4 | $4.33M | Sell |
54,373
-145,610
| -73% | -$11.6M | ﹤0.01% | 1602 |
|
|
2021
Q3 | $17.4M | Buy |
199,983
+171,014
| +590% | +$14.9M | 0.01% | 859 |
|
|
2021
Q2 | $3.73M | Buy |
28,969
+5,168
| +22% | +$665K | ﹤0.01% | 1741 |
|
|
2021
Q1 | $1.91M | Sell |
23,801
-34,927
| -59% | -$2.8M | ﹤0.01% | 2181 |
|
|
2020
Q4 | $4.79M | Buy |
58,728
+49,907
| +566% | +$4.07M | ﹤0.01% | 1544 |
|
|
2020
Q3 | $218K | Buy |
+8,821
| New | +$218K | ﹤0.01% | 3062 |
|